Loading ...

Laura Cooney, PhD

Immune Tolerance Network

Director, Biomarker Discovery Research â€“ Autoimmunity

Assessment Group

lcooney@immunetolerance.org

Work:

734-274-1149

Mobile:

Address:

Immune Tolerance Network

Committees:

,

Studies:

ITN075AI

-

Brentuximab Vedotin for Systemic Sclerosis

ITN077AI

-

Best Available Therapy Vs. Autologous Hematopoietic Stem Cell Transplant For MS

ITN080AI

-

Belimumab With Rituximab for Primary Membranous Nephropathy

ITN086AI

-

Evaluation of AMG 714 for Vitiligo

ITN091AI

-

VIBRANT: VIB4920 for Active Lupus Nephritis

ITN092AI

-

CD40L Antagonism in Rheumatoid Arthritis

ITN093AI

-

Daratumumab in Primary Antiphospholipid Syndrome

ITN829AI

-

ActoBio AG019 (L. lactis) and teplizumab

ITN830AI

-

DSG3-CAART for anti-DSG3 pemphigus vulgaris

ITN831AI

-

A Phase 2a Trial Of Teplizumab And RN168 In Patients With New Onset Type 1 Diabetes Mellitus

Bio:

Admin Links

Shortcuts

ITN Documents

Links